About

Zohar Gendler

Chairman

CEO and managing partner of NGT3 Incubator. Former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary Implantable bio-artificial pancreas) for a period of 8 years, brought the company to one of the world leaders positioning in the area.

Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years. Led the establishment and investment in more than 40 companies, such as Prolor Biotech (Opko), Mazor Robotics (Medtronic), Corindus (Siemens), ReWalk (NASDAQ: RWLK) and many others. Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies. M.Sc. in material engineering, B.Sc. in physics, and MBA, all from the Technion, Israel Institute of Technology.

Hernan Altman

Member of Board

Over 20 years’ experience in the MedDev industry – working with start-ups, large companies and global corporations. He fulfilled roles in R&D, IP, Quality, Clinical and Regulatory Affairs, leading multiple projects from early stages through clinical trials.

He is involved in over 30 patents and applications in medical imaging, detectors, neural stimulation and invasive cardiology. Former senior director R&D in Edwards life science, leading cutting-edge development of structural heart devices (SapienIII). Prior to that served as VP R&D and Application in Brainsgate, were he led negotiation and execution of IDE trial of over 800 patients, and department manager of system engineering at GE. Hernan brings strong skillset for taking medical devices from pipeline development through clinical trials and regulation.

Nizar Mishael

CFO

Nizar served as the Managing Partner and Chief Financial Officer for New Generation Technology incubator (NGT), where he supported over ten portfolio companies.

He managed the finances of these companies with strong leadership, closely following the budget, making sure the companies receive their full government money, and ensuring they set goals and achieve what they should (and when) with their funds. He has also taken an active role with follow-on funding and handling complex investment transactions. Previously, Nizar was the Chairman and Director of Positive Care. He holds Certified Public Accountant license with Greenberg & Shneor and holds a M.B.A. from Tel Aviv University.

Nitai Hanani

CEO & Co-founder

Over thirteen years of experience in cardiovascular and neuromodulation medical devices field in various R&D, engineering and management positions, from which seven with Enopace Biomedical – pioneering the conceptualization and development of intravascular neurostimulation device for treatment of heart failure.

Involved with companies in the fields of stroke treatment, renal denervation, peripheral interventional, acute kidney injury and ventilation monitoring. B.Sc., M.Sc. in Biomedical Engineering, Technion-IIT, Haifa, Israel Graduate project spun-off as startup (Pneumedicare) for ventilation monitoring. Conducted research in Cardiac Resynchronization Therapy, awarding him as young investigator award of the Israeli Society for Heart Research (ISHR).

Dr. Yair Feld

Medical Director & Founder

Dr. Yair Feld is a practicing cardiologist in Rambam Healthcare Campus. Yair has over 20 years of experience in managing life science companies and leading innovative research and development projects.
He founded several medical technology companies among which Nephera Ltd., Corassist Cardiovascular and Proarc. He has 10 years of experience in leading innovative research and development projects. Yair received his MD and PhD (physiology and biophysics) from the Technion-Israel Institute of Technology, as well as a BA is Physics from the University of Tel-Aviv.